蒽环类药物
| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| —— | 5-deoxydaunorubicin hydrochloride | 120295-15-0 | C27H29NO9*ClH |
| —— | 10-O-(4-O-acetyl-α-L-oleaudropyranosyl)daunorubicinone | 871567-69-0 | C30H32O12 |
| —— | (S)-N-[(2S,3S,4S,6R)-6-((1S,3S)-3-Acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-naphthacen-1-yloxy)-3-hydroxy-2-methyl-tetrahydro-pyran-4-yl]-2-amino-3-methyl-butyramide | 74892-68-5 | C32H38N2O11 |
| —— | daunomycin semicarbazone | 27908-32-3 | C28H32N4O10 |
| —— | 7-[4-O-(4-O-acetyl-2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)-2,3,6-trideoxy-3-N-trifluoroacetyl-α-L-lyxo-hexopyranosyl]daunorubicinone | 863503-15-5 | C39H44F3NO15 |
| —— | (2S,4S)-(+)-4-O-(2-deoxy-β-D-erythro-pentopyranosyl)-2-fluoroacetyl-2,4,5,12-tetrahydroxy-7-methoxy-1,2,3,4-tetrahydro-6,11-naphthacenedione | 120189-44-8 | C26H25FO11 |
| —— | 4-Bromo-benzoic acid [1-[(2S,4S)-4-((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-naphthacen-2-yl]-eth-(E)-ylidene]-hydrazide; hydrochloride | 110925-29-6 | C34H34BrN3O10*ClH |
| —— | 7-[4-O-(3,4-O-diacetyl-2,6-dideoxy-α-L-arabino-hexopyranosyl)-3-azido-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]daunorubicinone | 881035-78-5 | C37H41N3O15 |
| —— | (E)-5,6-Bis-[4-(tert-butyl-dimethyl-silanyloxy)-phenyl]-oct-5-enoic acid [(2S,3S,4S,6R)-6-((1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-naphthacen-1-yloxy)-3-hydroxy-2-methyl-tetrahydro-pyran-4-yl]-amide | 120743-62-6 | C59H77NO13Si2 |
| —— | N-[(2S,3S,4S,6R)-6-((1S,3S)-3-Acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-naphthacen-1-yloxy)-3-hydroxy-2-methyl-tetrahydro-pyran-4-yl]-2-amino-acetamide | 74892-63-0 | C29H32N2O11 |
| —— | N-[4-(daunorubicin-N-carbonyloxymethyl)-2-chlorophenyl] O-(methyl 2,3,4-tri-O-acetyl-β-D-glucopyranuronosyl) carbamate | 247075-29-2 | C49H51ClN2O23 |
| —— | (S)-4-Methyl-2-[(S)-2-(trityl-amino)-propionylamino]-pentanoic acid [(2S,3S,4S,6R)-6-((1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-naphthacen-1-yloxy)-3-hydroxy-2-methyl-tetrahydro-pyran-4-yl]-amide | 76542-80-8 | C55H59N3O12 |
| —— | 2-(pyridin-2-yldisulfaneyl)ethyl ((2S,3S,4S,6R)-6-(((1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl)oxy)-3-hydroxy-2-methyltetrahydro-2H-pyran-4-yl)carbamate | 1041170-93-7 | C35H36N2O12S2 |
| —— | 7-[4-O-(4-O-acetyl-2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl)-2,3,6-trideoxy-3-N-trifluoroacetyl-α-L-lyxo-hexopyranosyl]daunorubicinone | 863503-07-5 | C38H42F3NO15 |
| —— | 4-demethyl-3'-N3-daunorubicine | 1403987-61-0 | C26H25N3O10 |
| —— | 2-[(1-{2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-7-methoxy-4-{[(1S,3R,4aS,9S,9aR,10aS)-9-methoxy-1-methyloctahydro-1H-pyrano[4',3':4,5][1,3]oxazolo[2,3-c][1,4]oxazin-3-yl]oxy}-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl]ethoxy}cyclohexyl)oxy]acetamide | 1204819-69-1 | C40H48N2O15 |
| —— | 7-O-(3-amino-2,3,6-trideoxy-α-L-arabino-hexopyranosyl)-14-O-(tert-butyldiphenylsilyl)adriamycinone | 866614-83-7 | C43H47NO11Si |
| —— | doxorubicin (3-iodobenzoyl)hydrazone | 96096-05-8 | C34H34IN3O11 |
| —— | 10-descarbomethoxypyrromycin | 76069-71-1 | C28H33NO9 |
| —— | (2S,3S,4S,5R,6S)-6-(2-(3-(6-(2,5-dioxo-2H-pyrrol-1(5H)-yl)hexanamido)propanamido)-4-((2-(3-(3-hydroxy-2-methyl-6-((3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yloxy)-tetrahydro-2H-pyran-4-ylamino)propyl)oxazolidine-3-carbonyloxy)methyl)phenoxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid | 894096-06-1 | C60H71N5O25 |
| —— | Acetic acid 2-oxo-2-{(2S,4S)-2,5,12-trihydroxy-4-[(2R,4S,5S,6S)-5-hydroxy-6-methyl-4-(2,2,2-trifluoro-acetylamino)-tetrahydro-pyran-2-yloxy]-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-naphthacen-2-yl}-ethyl ester | 26388-53-4 | C31H30F3NO13 |
| —— | (2S,3S,4S,5R,6S)-6-(2-(3-aminopropanamido)-4-((2-(3-(3-hydroxy-2-methyl-6-((3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yloxy)-tetrahydro-2H-pyran-4-ylamino)propyl)oxazolidine-3-carbonyloxy)methyl)phenoxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid | 894096-08-3 | C50H60N4O22 |
| —— | H<sub>2</sub>N-Val-Ala-PABC-DOXO | 1394238-94-8 | C43H50N4O15 |
| —— | Fmoc-NH2-Ala-Leu-Ala-Leu-DNR | 208237-65-4 | C60H71N5O16 |
| —— | N-[4-(daunorubicin-N-carbonyloxymethyl)phenyl] O-β-D-galactopyranosyl carbamate | 186653-79-2 | C42H46N2O19 |
| —— | (8S-cis)-8-acetyl-10-((3-amino-2,3,6-trideoxy-α-L-lyxohexopyranosyl)oxy)-6a,7,8,9,10,10a-hexahydro-5,8,12-trihydroxy-1-methoxy-6,11-naphthacenedione | 118868-84-1 | C27H31NO10 |
| —— | 3-acetyl-3,5,12-trihydroxy-1-[5-hydroxy-4-(4-hydroxyphenylaminocarbonylamino)-6-methylperhydro-2-pyranoloxy]-10-methoxy-(1S,3S)-1,2,3,4,6,11-hexahydro-6,11-naphthacenedione | 371754-31-3 | C36H38N2O12 |
| —— | 929010-84-4 | C37H39N5O14 | |
| —— | 1-[2-(2-{(2S,3S,4S,6R)-3-Hydroxy-2-methyl-6-[(1S,3S)-3,5,12-trihydroxy-3-(2-hydroxy-acetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-naphthacen-1-yloxy]-tetrahydro-pyran-4-ylamino}-ethoxy)-ethyl]-pyrrole-2,5-dione | 872356-56-4 | C35H38N2O14 |
| —— | 3'-N,4'-O-di-trifluoroacetyldaunomycin | 219921-59-2 | C31H27F6NO12 |
| —— | 4-Nitro-benzoic acid (2S,3S,4S,6R)-6-((1S,3S)-3-acetyl-3-fluoro-5,12-dihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-naphthacen-1-yloxy)-4-allyloxycarbonylamino-2-methyl-tetrahydro-pyran-3-yl ester | 207394-52-3 | C37H33FN2O13 |
| —— | N-[N-(9-fluorenylmethoxycarbonyl)-β-alanyl-L-leucyl-L-alanyl-L-leucyl]doxorubicin | 274913-06-3 | C60H71N5O17 |
| —— | N-(pentafluoropropionyl)daunorubicin | 80242-49-5 | C30H28F5NO11 |
| —— | N-(heptafluorobutyryl)daunorubicin | 80242-50-8 | C31H28F7NO11 |
| —— | 138424-01-8 | C44H44N2O17 | |
| —— | 1338699-28-7 | C36H35NO13 | |
| —— | 1619241-04-1 | C34H39N3O11 | |
| —— | doxorubicin-5-formylsalicylamide | 850256-37-0 | C36H36N2O14 |
| —— | N-(pentafluoropropionyl)-9,10-anhydrodaunorubicin | 80242-56-4 | C30H26F5NO10 |
| —— | 3'-N-<trityl-α-(L)-alanyl>daunorubicin | 106518-49-4 | C49H48N2O11 |
| —— | N-(heptafluorobutyryl)-9,10-anhydrodaunorubicin | 80242-57-5 | C31H26F7NO10 |
| —— | 929010-83-3 | C37H37N3O15 | |
| —— | doxaliform | 850256-41-6 | C2H4O2*C36H36N2O14 |
| —— | N-(trifluoroacetyl)-9,10-anhydrodaunorubicin | 68168-17-2 | C29H26F3NO10 |
| —— | N-[3-hydroxy-2-methyl-6-[[3,5,12-trihydroxy-3-(1-hydroxyethyl)-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-2-yl]oxy]oxan-4-yl]acetamide | 62133-95-3 | C29H33NO11 |
| —— | 1313220-62-0 | C88H104N20O25 | |
| —— | (8S,10S)-8-Acetyl-6,8,11-trihydroxy-10-{(2R,5S,6S)-5-hydroxy-4-[(E)-hydroxyimino]-6-methyl-tetrahydro-pyran-2-yloxy}-1-methoxy-7,8,9,10-tetrahydro-naphthacene-5,12-dione | 125569-55-3 | C27H27NO11 |
| —— | 13-dihydrodaunorubicin | 28008-55-1 | C27H31NO10 |
| —— | 6-[[(2S,3S,4S,6R)-6-[[(1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]-3-hydroxy-2-methyloxan-4-yl]amino]-6-oxohexanoic acid | 264254-82-2 | C33H37NO13 |
| —— | NH2-Val-Ck-PABC-DOX | 1022094-34-3 | C46H56N6O16 |
联系我们
关注我们
公众号
